In-silico, in-vitro and ex-vivo evidence of combining silymarin phytopharmaceutical with piperine, and fulvic acid for enhancing its solubility and permeability

References

• Abend A, Curran D, Kuiper J, Lu X, Li H, Hermans A, Kotwal P, Diaz DA, Cohen MJ, Zhang L. 2019. Dissolution testing in drug product development: workshop summary report. AAPS J. 21(2):21.
   PubMed Web of Science ®Google Scholar
• Ahamad T. 2021. Workflow docking with autodock 4: a beginner’s guide.
   Google Scholar
• Alam MA, Al-Jenoobi FI, Al-Mohizea AM. 2012. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. J Pharm Pharmacol. 64(3):326–336. doi: 10.1111/j.2042-7158.2011.01391.x.
   PubMed Web of Science ®Google Scholar
• Al-Lazikani B. 2004. Rule of five (Lipinski Rule of Five).
   Google Scholar
• Aziz DM, Hama JR, Alam SM. 2015. Synthesising a novel derivatives of piperine from black pepper (Piper nigrum L.). Food Measure. 9(3):324–331. doi: 10.1007/s11694-015-9239-2.
   Web of Science ®Google Scholar
• Bano G, Raina RK, Zutshi U, Bedi KL, Johri RK, Sharma SC. 1991. Effect of piperine on bioavailability and pharmacokinetics of propranolol and theophylline in healthy volunteers. Eur J Clin Pharmacol. 41(6):615–617. doi: 10.1007/BF00314996.
   PubMed Web of Science ®Google Scholar
• Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 9(6):7204–7218. doi: 10.18632/oncotarget.23208.
   PubMedGoogle Scholar
• Daina A, Michielin O, Zoete V. 2017. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 7:42717. doi: 10.1038/srep42717.
   PubMed Web of Science ®Google Scholar
• Dickinson PA, Lee WW, Stott PW, Townsend AI, Smart JP, Ghahramani P, Hammett T, Billett L, Behn S, Gibb RC, et al. 2008. Clinical relevance of dissolution testing in quality by design. Aaps J. 10(2):380–390. doi: 10.1208/s12248-008-9034-7.
   PubMed Web of Science ®Google Scholar
• Dressman JB, Krämer J. 2005. Pharmaceutical dissolution testing. Raton, FL: Taylor & Francis Boca.
   Google Scholar
• Eedara BB, Veerareddy PR, Jukanti R, Bandari S. 2014. Improved oral bioavailability of fexofenadine hydrochloride using lipid surfactants: ex vivo, in situ and in vivo studies. Drug Dev Ind Pharm. 40(8):1030–1043. doi: 10.3109/03639045.2013.801984.
   PubMed Web of Science ®Google Scholar
• El-Kattan AF, Varma MV, Steyn SJ, Scott DO, Maurer TS, Bergman A. 2016. Projecting ADME Behavior and Drug-Drug Interactions in Early Discovery and Development: application of the Extended Clearance Classification System. Pharm Res. 33(12):3021–3030. eng. doi: 10.1007/s11095-016-2024-z.
   PubMed Web of Science ®Google Scholar
• Elmezayen A. 2020. AutoDock tutorial.
   Google Scholar
• General Chapter. 2019. US pharmacopoeia.
   Google Scholar
• Gillessen A, Schmidt HH. 2020. Silymarin as supportive treatment in liver diseases: a narrative review. Adv Ther. 37(4):1279–1301. eng. doi: 10.1007/s12325-020-01251-y.
   PubMed Web of Science ®Google Scholar
• Gnananath K, Nataraj KS, Rao BG, Kumar KP, Mahnashi MH, Anwer MK, Umar A, Iqbal Z, Mirza MA. 2020. Exploration of fulvic acid as a functional excipient in line with the regulatory requirement. Environ Res. 187:109642. doi: 10.1016/j.envres.2020.109642.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Bansal P, Bhardwaj RK, Velpandian T. 2000. Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol Res. 41(6):657–662. doi: 10.1006/phrs.1999.0640.
   PubMed Web of Science ®Google Scholar
• Javed S, Ahsan W, Kohli K. 2016. The concept of bioenhancers in bioavailability enhancement of drugs–a patent review. J Sci Lett. 1:143–165.
   Google Scholar
• Javed S ,Kohli K ,Ahsan W. 2016. Solubility and dissolution enhancement of silymarin with fulvic acid carrier. Inter J Drug Develop Res. 8(1):9–14.
   Google Scholar
• Jin MJ, Han HK. 2010. Effect of piperine, a major component of black pepper, on the intestinal absorption of fexofenadine and its implication on food-drug interaction. J Food Sci. 75(3):H93–96. eng. doi: 10.1111/j.1750-3841.2010.01542.x.
   PubMed Web of Science ®Google Scholar
• Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N. 2011. Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res. 55(8):1169–1176. eng. doi: 10.1002/mnfr.201100117.
   PubMed Web of Science ®Google Scholar
• Kalopitas G, Antza C, Doundoulakis I, Siargkas A, Kouroumalis E, Germanidis G, Samara M, Chourdakis M. 2021. Impact of Silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition. 83:111092. doi: 10.1016/j.nut.2020.111092.
   PubMed Web of Science ®Google Scholar
• Kasibhatta R, Naidu MUR. 2007. Influence of piperine on the pharmacokinetics of nevirapine under fasting conditions. Drugs R D. 8(6):383–391. doi: 10.2165/00126839-200708060-00006.
   PubMedGoogle Scholar
• Khan R, Jain P, Zakir F, Aqil M, Alshehri S, Mirza MA, Iqbal Z. 2022. Quality and in vivo assessment of a fulvic acid complex: a validation study. Sci Pharm. 90(2):33. doi: 10.3390/scipharm90020033.
   Web of Science ®Google Scholar
• Lambert JD, Hong J, Kim DH, Mishin VM, Yang CS. 2004. Piperine enhances the bioavailability of the tea polyphenol (−)-epigallocatechin-3-gallate in mice. J Nutr. 134(8):1948–1952. doi: 10.1093/jn/134.8.1948.
   PubMed Web of Science ®Google Scholar
• Mayer K, Myers R, Lee S. 2005. Silymarin treatment of viral hepatitis: a systematic review. J Viral Hepat. 12(6):559–567. doi: 10.1111/j.1365-2893.2005.00636.x.
   PubMed Web of Science ®Google Scholar
• Mirza MA, Ahmad N, Agarwal SP, Mahmood D, Anwer MK, Iqbal Z. 2011. Comparative evaluation of humic substances in oral drug delivery. Results Pharma Sci. 1(1):16–26. doi: 10.1016/j.rinphs.2011.06.001.
   PubMedGoogle Scholar
• Pattanaik S, Hota D, Prabhakar S, Kharbanda P, Pandhi P. 2009. Pharmacokinetic interaction of single dose of piperine with steady-state carbamazepine in epilepsy patients. Phytother Res. 23(9):1281–1286. eng. doi: 10.1002/ptr.2676.
   PubMed Web of Science ®Google Scholar
• Ralli T, Kalaiselvan V, Tiwari R, Shukla S, Kohli K. 2021. Clinical and Regulatory Status of Silymarin. Appl Drug Res Clinical Trials Regul Affairs. 8(2):104–111.
   Google Scholar
• Ralli T, Neupane YR, Saifi Z, Kohli K. 2021. Gut microbiota as an emerging therapeutic avenue for the treatment of nonalcoholic fatty liver disease. Curr Pharm Des. 27(46):4677–4685. doi: 10.2174/1389201022666210625141526.
   PubMed Web of Science ®Google Scholar
• Ralli T, Saifi Z, Tyagi N, Vidyadhari A, Aeri V, Kohli K. 2022. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease. Crit Rev Microbiol. 1-9.doi: 10.1080/1040841X.2022.2142091.
   PubMed Web of Science ®Google Scholar
• Ralli T, Tripathi T, Kalaiselvan V, Tiwari R, Aeri V, Kohli K. 2023. Silymarin as a Phyto-pharmaceutical: isolation, simultaneous quantification of four biomarkers and in-silico anti-inflammatory activity. Chin J Anal Chem. 51(3):100174. doi: 10.1016/j.cjac.2022.100174.
   Web of Science ®Google Scholar
• Saifi Z, Rizwanullah M, Mir SR, Amin S. 2020. Bilosomes nanocarriers for improved oral bioavailability of acyclovir: a complete characterization through in vitro, ex-vivo and in vivo assessment. J Drug Delivery Sci Technol. 57:101634. doi: 10.1016/j.jddst.2020.101634.
   Web of Science ®Google Scholar
• Sander T. 2001. OSIRIS property explorer. Organic Chemistry Portal. https://wwworganic-chemistryorg/prog/peo/
   Google Scholar
• Silymarin. 2019. Indian pharmacopoeia.
   Google Scholar
• Singh A, Deep A. 2011. Piperine: a bioenhancer. Intern J Pharm Res Technol. 1(1):01–05.
   Google Scholar
• Soleimani V, Delghandi PS, Moallem SA, Karimi G. 2019. Safety and toxicity of silymarin, the major constituent of milk thistle extract: an updated review. Phytother Res. 33(6):1627–1638. doi: 10.1002/ptr.6361.
   PubMed Web of Science ®Google Scholar
• Vilar-Gomez E, Vuppalanchi R, Gawrieh S, Ghabril M, Saxena R, Cummings OW, Chalasani N. 2018. Vitamin E improves transplant-free survival and hepatic decompensation among patients with NASH and advanced fibrosis. Hepatology. 71(2):495–509.
   Web of Science ®Google Scholar
• Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, Wang N, Feng Y. 2020. Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application. Front Pharmacol. 11:601.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Loomba R, Rinella ME, Bugianesi E, Marchesini G, Neuschwander-Tetri BA, Serfaty L, Negro F, Caldwell SH, Ratziu V, et al. 2018. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 68(1):361–371. doi: 10.1002/hep.29724.
   PubMed Web of Science ®Google Scholar
• Zhang L, Yao Z, Ji G. 2018. Herbal extracts and natural products in alleviating non-alcoholic fatty liver disease via activating autophagy. Front Pharmacol. 9:1459.
   PubMed Web of Science ®Google Scholar